Nanomedicine News

RSS
Nanoparticle-Based Therapeutics Manufacturer Nanocopoeia Launches New Website

Nanoparticle-Based Therapeutics Manufacturer Nanocopoeia Launches New Website

Researchers Develop New Capsule for Controlled Drug Delivery Using Silica Nanosheets

Researchers Develop New Capsule for Controlled Drug Delivery Using Silica Nanosheets

BBI Exhibits Lateral Flow Diagnostic Technology at BIO Convention 2012

BBI Exhibits Lateral Flow Diagnostic Technology at BIO Convention 2012

Spectrum Pharmaceuticals Starts Phase I Study of Nanotechnology Compound, RenaZorb

Spectrum Pharmaceuticals Starts Phase I Study of Nanotechnology Compound, RenaZorb

DELRUS to Distribute MagForce’s NanoTherm Therapy in Russia and CIS Countries

Toxicity Study Ensures Safety of Quantum Dots in Nanomedicine Applications

Toxicity Study Ensures Safety of Quantum Dots in Nanomedicine Applications

New Polymer Allows Improved Method for Preparation of Nanoparticles for Drug Delivery

Study Reveals DNA Nanoparticle Delivery System Itself has Therapeutic Value

Study Reveals DNA Nanoparticle Delivery System Itself has Therapeutic Value

Senesco to Deliver Presentation on eIF5A-Based Nanoparticle for Multiple Myeloma Treatment

Senesco to Deliver Presentation on eIF5A-Based Nanoparticle for Multiple Myeloma Treatment

Alnylam Reports Final Phase I Clinical Study Results of Lipid Nanoparticle-Based ALN-TTR01

Alnylam Reports Final Phase I Clinical Study Results of Lipid Nanoparticle-Based ALN-TTR01

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.